Concepedia

Junjie Li

JL

16

Publications

1K

Citations

13

H-Index

2007

Active since

Affiliations

Fudan University Shanghai Cancer Center(Current)

Shanghai Medical College of Fudan University

Jiangsu Hengrui Medicine (China)

Shanghai Jiao Tong University

Shanghai First People's Hospital

Junjie Li is an author at Fudan University Shanghai Cancer Center specializing in breast cancer, medicine, and oncology.

ORCID

Top concepts

Publications per year

2007–2024

16

Publications

16

Challenges to effective cancer control in China, India, and Russia

Paul E. Goss, Kathrin Strasser‐Weippl, Brittany Bychkovsky et al. · The Lancet Oncology · 2014 · 497 citations

, , +9

Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial

Junjie Li, Ke‐Da Yu, Da Pang et al. · Journal of Clinical Oncology · 2020 · 103 citations · Full text

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Li Chen, Yi‐Zhou Jiang, Song‐Yang Wu et al. · Clinical Cancer Research · 2022 · 89 citations · Full text

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial

Lei Fan, Zhonghua Wang, Linxiaoxi Ma et al. · The Lancet Oncology · 2024 · 55 citations

, , +5

Expression of Concern: TIEG1 induces apoptosis through mitochondrial apoptotic pathway and promotes apoptosis induced by homoharringtonine and velcade

Wei Jin, Gen‐Hong Di, Junjie Li et al. · FEBS Letters · 2007 · 41 citations · Full text

Rows per page

1–5 of 16